(2R,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane CAS 98760-08-8 Atazanavir Intermediate High Purity
Manufacturer Supply Atazanavir Related Intermediates
Moc-L-Tert-Leucine CAS 162537-11-3
4-(2-Pyridyl)benzaldehyde CAS 127406-56-8
(2S,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane CAS 98737-29-2
(2R,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane CAS 98760-08-8
tert-Butyl 2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate CAS 198904-85-7
Atazanavir CAS 198904-31-3
Atazanavir Sulfate CAS 229975-97-7
High Quality, Commercial Production
Chemical Name | (2R,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane |
Synonyms | (2R,3S)-3-(tert-Boc)amino-1,2-epoxy-4-phenylbutane; (2R,3S)-3-(tert-Butoxycarbonyl)amino-1,2-epoxy-4-phenylbutane; Atazanavir Intermediate; Atazanavir Impurity C; threo-N-Boc-L-phenylalanine epoxide |
CAS Number | 98760-08-8 |
CAT Number | RF-PI288 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C15H21NO3 |
Molecular Weight | 263.34 |
Shipping Condition | Under Ambient Temperature |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | White to Off-White Crystalline Powder |
Identification | The identification is confirmed by HPLC RT |
Solubility | Soluble in Methanol |
Specific Rotation | -10°~ -20° |
Water (K.F) | ≤0.50% |
Residue on Ignition | ≤0.20% |
Related Substances | |
Impurity (RRT0.97) | ≤0.30% |
Any Single Impurity | ≤0.30% |
Total Impurities | ≤1.0% |
Heavy Metals | ≤20ppm |
Purity / Analysis Method | ≥99.0% (HPLC) |
Enantiomeric Purity | ≤0.30% |
Test Standard | Enterprise Standard |
Usage | Intermediate of Atazanavir (CAS 198904-31-3) HIV-1 Protease Inhibitor |
Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (2R,3S)-1,2-Epoxy-3-(Boc-Amino)-4-Phenylbutane (CAS 98760-08-8) with high quality, an intermediate of Atazanavir (CAS 198904-31-3) and Atazanavir Sulfate (CAS 229975-97-7). Atazanavir is a novel azapeptide HIV protease inhibitor (PI).
Atazanavir is an inhibitor of human immunodeficiency virus type 1 (HIV-1) protease, an enzyme that is essential for the processing of Gag and Gag-Pol polyproteins into structural and enzymatic proteins required for viral replication. It has a similar pharmacophore motif to the other six widely marketed HIV protease inhibitors, most of which are based upon a hydroxyethylamine template. Uniquely, it possesses an aza-peptide motif but maintains many similar pharmacophore elements including lipophilic moieties that presumably bind to S2, S1, S′1, and S′2 positions.